Screener
Evolent Health, Inc. EVH Reportable segment — Loss from equity method investees
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.
The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:53 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628908-26-000086
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Selling, general and administrative expenses excluding other segment items (3) | 53,481 | 63,888 | 115,707 | 130,156 |
| Depreciation and amortization expenses | 21,566 | 23,141 | 43,121 | 47,199 |
| Interest income | (703) | (1,084) | (1,717) | (2,358) |
| Interest expense | 16,859 | 11,601 | 33,727 | 21,986 |
| Gain (loss) from equity method investees | 41 | (197) | 52 | (178) |
| Provision for (benefit from) income taxes | 2,715 | (825) | 3,625 | 645 |
| Other segment items (4) | 15,936 | 56,001 | 26,305 | 130,453 |
| Net loss attributable to common shareholders of Evolent Health, Inc. | $(28,364) | $(51,090) | $(54,996) | $(123,340) |
Item 1. Financial Statements
FAQ
- What is Evolent Health, Inc.'s reportable segment — loss from equity method investees?
- Evolent Health, Inc. (EVH) reported reportable segment — loss from equity method investees of -$41K in Q2 2026.
- How has Evolent Health, Inc.'s reportable segment — loss from equity method investees changed year-over-year?
- Evolent Health, Inc.'s reportable segment — loss from equity method investees decreased by 120.8% year-over-year, from $197K to -$41K.
- What is the long-term trend for Evolent Health, Inc.'s reportable segment — loss from equity method investees?
- Over 3 years (2022 to 2025), Evolent Health, Inc.'s reportable segment — loss from equity method investees has grown at a -56.9% compound annual growth rate (CAGR), from $4.57M to $365K.
- What does reportable segment — loss from equity method investees mean?
- This reflects the segment's proportional share of losses from entities in which it holds a significant influence but not full control. It highlights the financial performance of strategic partnerships and joint ventures within the segment's ecosystem.
Ask your AI about Evolent Health, Inc.'s reportable segment — loss from equity method investees.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude